Stay updated on ADG126 + Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page.

Latest updates to the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe Record History now includes a new Revision: v3.5.4 entry as part of the version history, and the previous Revision: v3.5.3 entry has been removed from the list. This reflects a minor site release update rather than any change to trial data or descriptions.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe page’s developer/version footer was updated from Revision v3.5.2 to v3.5.3, reflecting a site release rather than a study record change.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded revision: v3.5.2 and removed revision: v3.5.0 from the record history.SummaryDifference0.1%

- Check73 days agoChange DetectedAdded Revision: v3.5.0 and deleted Revision: v3.4.3 in the Record History.SummaryDifference0.1%

- Check80 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the study record history.SummaryDifference0.1%

- Check109 days agoChange DetectedThe history shows a new site revision v3.4.2 added, and the government funding notice as well as the v3.4.1 revision entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

Stay in the know with updates to ADG126 + Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page.